genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
News
Drug Delivery via Biohybrid Microswimmers a Flagellum Lash Closer
News
Genetic Activity in Prenatal Development and Early Childhood Implants Seeds of…
Coronavirus
Clinical Trial Evaluating Oral Drug against Coronavirus Expected to Start Later…
News
Disrupting Pancreatic Cancer pH May Hold Therapeutic Potential
Coronavirus
Coronavirus Picks on Some Cells More Than Others
Insights
All
Trends for 2020
Cell Therapy
Cell and Gene Therapy Sector Needs to Automate
Bioprocessing
The Right Start is Crucial
Bioprocessing
Going from Small to Big in Bioprocessing: Roadblocks and Their Resolution
Commentary
Understanding Glycans in COVID-19 Drug Design
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Drug Delivery via Biohybrid Microswimmers a Flagellum Lash Closer
Upcoming Webinars
Self-Amplifying mRNA Vaccines for Pandemic Rapid Response
Upcoming Webinars
Improving Plasmid and Viral Vectors in Cell and Gene Therapy
Coronavirus
Clinical Trial Evaluating Oral Drug against Coronavirus Expected to Start Later…
Magazine
All
Special Report
Supplement
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
April 2020 Vol. 40 No.4
Cancer Drug Discovery’s “RASzle-Dazzle”
April 2020 Vol. 40 No.4
Coordinating the Move to Bioprocessing 4.0
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Self-Amplifying mRNA Vaccines for Pandemic Rapid Response
Upcoming Webinars
Improving Plasmid and Viral Vectors in Cell and Gene Therapy
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Roche
Roche
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Roche
Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment
Roche
Declaring National Emergency, Trump Vows Accelerated COVID-19 Testing
Roche
Assessing Coronavirus Impact on Wall Street
Roche
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Roche
Illumina Unveils New Sequencing Systems, Roche Clinical Dx Collaboration
Roche
Roche Buys Ex-U.S. Rights to Sarepta DMD Gene Therapy Candidate SRP-9001...
Roche
Roche to Expand Fibrotic Disease Pipeline with Up-to-$1.4B Promedior Acquisition
Roche
Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
Roche
Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary...
Roche
Roche Extends Offer for Spark Therapeutics a Second Time, as Shareholders...
Roche
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Roche
Roche-Licensed Rare Disease Drug at Center of Ipsen’s Up-to-$1.3B Clementia Acquisition
Roche
Roche Expands into Gene Therapy with Planned $4.8B Acquisition of Spark...
Roche
Genentech to Develop Xencor IL-15 Cytokines in Immuno-Oncology Partnership
Roche
Genentech’s Crenezumab Fails Two Phase III Trials in Alzheimer’s
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
